Found: 22
Select item for more details and to access through your institution.
Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 892, doi. 10.1111/dom.12869
- By:
- Publication type:
- Article
Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 866, doi. 10.1111/dom.12894
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Sequential or simultaneous start?
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 909, doi. 10.1111/dom.12897
- By:
- Publication type:
- Article
Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 883, doi. 10.1111/dom.12899
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 763, doi. 10.1111/dom.12771
- Publication type:
- Article
Renal safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 897, doi. 10.1111/dom.12876
- By:
- Publication type:
- Article
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 791, doi. 10.1111/dom.12877
- By:
- Publication type:
- Article
Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 800, doi. 10.1111/dom.12878
- By:
- Publication type:
- Article
Evaluation of the long-term cost-effectiveness of liraglutide vs lixisenatide for treatment of type 2 diabetes mellitus in the UK setting.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 842, doi. 10.1111/dom.12890
- By:
- Publication type:
- Article
Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 850, doi. 10.1111/dom.12891
- By:
- Publication type:
- Article
Safety and efficacy of IDegLira titrated once weekly versus twice weekly in patients with type 2 diabetes uncontrolled on oral antidiabetic drugs: DUAL VI randomized clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 858, doi. 10.1111/dom.12892
- By:
- Publication type:
- Article
The emerging role of metformin in gestational diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 765, doi. 10.1111/dom.12893
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 912, doi. 10.1111/dom.12965
- Publication type:
- Article
Basal rate tests (24-hour fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles: A randomized controlled prospective trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 783, doi. 10.1111/dom.12868
- By:
- Publication type:
- Article
Efficacy and safety of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24-week, randomized, double-blind, placebo-controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 874, doi. 10.1111/dom.12898
- By:
- Publication type:
- Article
Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 809, doi. 10.1111/dom.12881
- By:
- Publication type:
- Article
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 814, doi. 10.1111/dom.12882
- By:
- Publication type:
- Article
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 901, doi. 10.1111/dom.12884
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 906, doi. 10.1111/dom.12885
- By:
- Publication type:
- Article
Observational Registry of Basal Insulin Treatment ( ORBIT) in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic drugs: Real-life use of basal insulin in China.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 822, doi. 10.1111/dom.12886
- By:
- Publication type:
- Article
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 831, doi. 10.1111/dom.12889
- By:
- Publication type:
- Article
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 773, doi. 10.1111/dom.12830
- By:
- Publication type:
- Article